首页 › 基金 › Checkpoint Capital L.P. › OCS

Checkpoint Capital L.P. 对 OCS 的持仓历史

OCULIS HOLDING AG · 医疗保健

Checkpoint Capital L.P. 在 Q3 2026 的 13F 申报中披露持有 OCS(OCULIS HOLDING AG)99,500 股,市值约 US$929K,约占其申报组合的 0.21%,在其申报持仓中市值排名第 8 位。 Checkpoint Capital L.P. 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)99.50K 股
申报持仓市值$929.33K
组合权重0.21%
首次申报Q3 2026
最近变动新进
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Checkpoint Capital L.P. 对 OCS 的持仓演变

Checkpoint Capital L.P. 于 Q3 2026 首次披露 OCS 持仓:99,500 股(约 US$929K)。

逐季持仓明细

季度股数金额变化
Q3 2026 99.50K $929.33K 新进

关于 OCS 与 13F 数据

OCS(OCULIS HOLDING AG)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 OCS,申报仓位最大的包括:EQT Fund Management S.a r.l. (US$64.9M), Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$15.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 OCS 的基金

查看 OCS 的全部基金持有人 →

常见问题

How long has Checkpoint Capital L.P. held OCS?

Checkpoint Capital L.P. has disclosed OCS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Checkpoint Capital L.P.'s current position in OCS?

As of Q3 2026, Checkpoint Capital L.P. holds 99.50K shares of OCS (OCULIS HOLDING AG), valued at $929.33K, representing 0.21% of its reported portfolio and ranking #8.

Has Checkpoint Capital L.P. been buying or selling OCS?

In the latest 13F filing (Q3 2026), Checkpoint Capital L.P. newly opened its position in OCS.

Which other funds hold OCS?

Other major institutional holders of OCS include EQT Fund Management S.a r.l., Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.